Table 3.
Atherosclerotic Event or All-Cause Death | Heart Failure or All-Cause Death | |||
---|---|---|---|---|
Model | Non-Hispanic Black vs. Non-Hispanic White |
Hispanic vs. Non-Hispanic White |
Non-Hispanic Black vs. Non-Hispanic White |
Hispanic vs. Non-Hispanic White |
1 | 1.15 (0.98-1.35) | 1.07 (0.74-1.55) | 1.37 (1.17-1.60) | 1.19 (0.84-1.68) |
2 | 1.06 (0.89-1.25) | 1.06 (0.72-1.56) | 1.18 (1.00-1.39) | 1.04 (0.73-1.49) |
3 | 0.97 (0.82-1.15) | 0.90 (0.61-1.34) | 1.09 (0.92-1.28) | 0.84 (0.59-1.22) |
4 | 0.87 (0.73-1.04) | 0.93 (0.62-1.38) | 1.01 (0.85-1.20) | 0.84 (0.58-1.22) |
5 | 0.83 (0.69-0.99) | 0.89 (0.60-1.33) | 0.99 (0.83-1.18) | 0.81 (0.56-1.18) |
6 | 0.84 (0.70-1.00) | 0.93 (0.62-1.38) | 0.95 (0.80-1.14) | 0.82 (0.56-1.19) |
7 | 0.83 (0.69-1.00) | 0.96 (0.65-1.43) | 0.96 (0.80-1.14) | 0.86 (0.59-1.25) |
Note: Values are given as adjusted hazard ratio (95% confidence interval). Model 1: Clinical site; Model 2: Model 1 + sociodemographic characteristics, nephrology care; Model 3: Model 2+ baseline estimated glomerular filtration rate, proteinuria; Model 4: Model 3 + baseline cardiovascular risk factors, cardiovascular medication; Model 5: Model 4 + baseline markers mineral metabolism; Model 6: Model 4 + measures of anemia and inflammation (hemoglobin and C-reactive protein); Model 7: Model 4 + measures of subclinical ischemia (cardiac troponin I and T)